Oxbridge Re (NASDAQ:OXBR – Get Free Report) announced its quarterly earnings data on Monday. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.04, reports. The company had revenue of $0.58 million during the quarter, compared to analysts’ expectations of $0.70 million. Oxbridge Re had a negative net margin of 80.68% and a negative return on equity of 34.34%.
Here are the key takeaways from Oxbridge Re’s conference call:
- SurancePlus tokenization and distribution progress — including entry into the Solana ecosystem and LayerZero/AlphaLedger connectivity across 160+ networks — meaningfully broadens investor access to on?chain reinsurance and should support future growth.
- Management recorded significant underwriting losses tied to Hurricane Milton, driving the combined ratio to a very high 264% for FY2025 and materially increasing expense and loss ratios versus the prior year.
- Revenue improved to $2.58M for FY2025 (from $546k prior year) and the company narrowed its annual net loss to $2.08M (versus $2.73M), while the most recent quarter produced $120k net income, reflecting higher investment/other income and allocation of underwriting losses to token holders.
- Strong liquidity position with approximately $6.9M in cash and restricted cash as of Dec 31, 2025, which management says supports tokenization initiatives and potential expansion into additional real?world assets such as tokenized data center revenue.
Oxbridge Re Trading Up 36.0%
Shares of OXBR stock opened at $1.18 on Wednesday. Oxbridge Re has a twelve month low of $0.76 and a twelve month high of $2.86. The company’s 50-day moving average price is $1.03 and its 200-day moving average price is $1.36. The stock has a market cap of $9.06 million, a price-to-earnings ratio of -4.37 and a beta of 2.27.
Hedge Funds Weigh In On Oxbridge Re
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oxbridge Re in a report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $5.00.
Get Our Latest Stock Report on OXBR
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Read More
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
